This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04296/identifier/pdb/
n13http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB04296/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04296/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04296/identifier/drugbank/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04296
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04296 n13:DB04296
dcterms:title
5-Oxo-L-Norleucine
adms:identifier
n8:28125466 n10:46509131 n11:DB04296 n12:ONL
n3:IUPAC-Name
n4:271B4D14-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4D1A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4D19-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4D16-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4D17-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4D18-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4D12-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4D10-363D-11E5-9242-09173F13E4C5 n4:271B4D13-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4D11-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4D20-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4D21-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4D1B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4D1C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4D1E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4D1D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4D1F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4D26-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4D28-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4D29-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4D25-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4D24-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4D27-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4D15-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4D22-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4D23-363D-11E5-9242-09173F13E4C5